{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:21:27Z","timestamp":1791555687377,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171849"],"award-info":[{"award-number":["81171849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbrc.2013.04.018","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T14:33:19Z","timestamp":1366641199000},"page":"809-814","source":"Crossref","is-referenced-by-count":19,"title":["Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1"],"prefix":"10.1016","volume":"434","author":[{"given":"Gongquan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liushun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.04.018_b0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(04)01508-6","article-title":"Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum","volume":"5","author":"Burroughs","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1634\/theoncologist.2010-S4-23","article-title":"The challenge of prognosis and staging for hepatocellular carcinoma","volume":"15","author":"Marrero","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2013.04.018_b0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0020","first-page":"133","article-title":"Apoptosis: the biochemistry and molecular biology of programmed cell death","volume":"14","author":"Schwartzman","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2013.04.018_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2013.04.018_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochromec-mediatedapoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2013.04.018_b0035","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1190217","article-title":"BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program","volume":"330","author":"Ren","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.04.018_b0040","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2013.04.018_b0045","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","article-title":"Mcl-1 is a potential therapeutic target in multiple types of cancer","volume":"66","author":"Akgul","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2013.04.018_b0050","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.20696","article-title":"Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy","volume":"101","author":"Kim","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2013.04.018_b0055","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2013.04.018_b0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc2615","article-title":"Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics","volume":"9","author":"Cragg","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2013.04.018_b0065","first-page":"525","article-title":"Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignancies","volume":"43","author":"Khaw","year":"2011","journal-title":"Pathol. J. RCPA"},{"key":"10.1016\/j.bbrc.2013.04.018_b0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008469-200206000-00011","article-title":"Butyrate and aspirin in combination have an enhanced effect on apoptosis in human colorectal cancer cells","volume":"11","author":"Menzel","year":"2002","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbrc.2013.04.018_b0075","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1158\/1078-0432.CCR-07-4622","article-title":"Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models","volume":"14","author":"Shoemaker","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2013.04.018_b0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","article-title":"Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors","volume":"29","author":"Gandhi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0085","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.23836","article-title":"The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib","volume":"52","author":"Hikita","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2013.04.018_b0090","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00280-009-1232-1","article-title":"The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo","volume":"66","author":"Ackler","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00280-011-1763-0","article-title":"ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein","volume":"69","author":"Wang","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0100","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cellsig.2012.05.009","article-title":"Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1","volume":"24","author":"Zhang","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2013.04.018_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2013.04.018_b0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tiv.2010.01.010","article-title":"Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1\/2 and AKT","volume":"24","author":"Park","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bbrc.2013.04.018_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2012.06.067","article-title":"Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1\/2 activation in human cervical cancer cells","volume":"424","author":"Im","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.04.018_b0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10495-009-0424-9","article-title":"Aspirin induces apoptosis in human leukemia cells independently of NF-\u03baB and MAPKs through alteration of the Mcl-1\/Noxa balance","volume":"15","author":"Iglesias-Serret","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2013.04.018_b0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/0008-5472.CAN-11-3240","article-title":"Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737","volume":"72","author":"Song","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2013.04.018_b0130","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","article-title":"A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence","volume":"99","author":"Jacobs","year":"2007","journal-title":"JNCI"},{"key":"10.1016\/j.bbrc.2013.04.018_b0135","first-page":"559","article-title":"Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2013.04.018_b0140","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1158\/1078-0432.CCR-07-4362","article-title":"Aspirin sensitizes cancer cells to TRAIL\u2013induced apoptosis by reducing survivin levels","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2013.04.018_b0145","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1124\/mol.107.039610","article-title":"Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation","volume":"72","author":"Yoo","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.04.018_b0150","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","article-title":"Aspirin, salicylates, and cancer","volume":"373","author":"Elwood","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbrc.2013.04.018_b0180","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1038\/cddis.2011.109","article-title":"Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263\/737-induced apoptosis","volume":"2","author":"Yamaguchi","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2013.04.018_b0185","doi-asserted-by":"crossref","first-page":"e6651","DOI":"10.1371\/journal.pone.0006651","article-title":"RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway","volume":"4","author":"Keuling","year":"2009","journal-title":"PLoS ONE."},{"key":"10.1016\/j.bbrc.2013.04.018_b0190","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1158\/1535-7163.MCT-10-1091","article-title":"Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cancer Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1300644X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1300644X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T17:30:49Z","timestamp":1539711049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1300644X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0006291X1300644X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.04.018","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}